Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

What Science Has to Say About CBD

If you’ve used CBD for these reasons above, you might enjoy peace of mind knowing scientists have found the possible benefits you’ve known all along. . . . → Read More: What Science Has to Say About CBD

Trial Begins for Multi-Neurological Disease Therapy

Neurons

A clinical trial is underway testing a new type of therapy its developer says addresses damage to nerve cells associated with a number of neurological disorders. . . . → Read More: Trial Begins for Multi-Neurological Disease Therapy

Grant Funds Typhoid Vaccine Patch Development

Salmonella Typhi bacteria

A health research foundation grant is funding development of a vaccine protecting against typhoid fever, given in a patch from from a spring-loaded device. . . . → Read More: Grant Funds Typhoid Vaccine Patch Development

HHS Directs $100M for Covid-19 Venture Investments

Global Covid-19

The Department of Health and Human Services is allocating $100 million for venture investments in new technologies to prepare for future threats from Covid-19. . . . → Read More: HHS Directs $100M for Covid-19 Venture Investments

Company Gains Ultrasound-Linked Drug Capsule Technology

DNA bubbles illustration

A company developing a drug delivery process with treatments activated by ultrasound received an option to license a key technology from its founders’ university labs. . . . → Read More: Company Gains Ultrasound-Linked Drug Capsule Technology

Biotech, A.I. Companies Model Animal Studies/Clinical Trials

Zebrafish

A discoverer of neuroscience therapies and a genomics data science company are developing machine learning models to predict clinical trial outcomes for ADHD drugs. . . . → Read More: Biotech, A.I. Companies Model Animal Studies/Clinical Trials

Trial Underway Testing Stem Cell Particles for Burns

Exosome illustration

A clinical trial has begun testing an experimental treatment for burns using off-the-shelf therapeutic particles derived from human bone marrow stem cells. . . . → Read More: Trial Underway Testing Stem Cell Particles for Burns

Industry, Univ. Labs Partner on Parkinson’s Digital Biomarkers

neurons

A developer of electronic health data tools and a university’s neuroscience labs are collaborating on tests of Parkinson’s disease drugs using digital measures of patient functioning. . . . → Read More: Industry, Univ. Labs Partner on Parkinson’s Digital Biomarkers

Regeneron Acquires Hearing Loss Biotech in $213M Deal

Headphones sound waves graphic

Regeneron Pharmaceuticals, a maker of synthetic biologic treatments, is acquiring Decibel Therapeutics, developer of gene therapies to treat hearing loss and balance disorders. . . . → Read More: Regeneron Acquires Hearing Loss Biotech in $213M Deal

Companies to Assess Ovarian Health Biotech Drug

Women silhouettes

A women’s health biotechnology company is partnering with a Brazilian drug maker to evaluate a precision target and treatment for ovarian health disorders. . . . → Read More: Companies to Assess Ovarian Health Biotech Drug